SK

Sanjiv Kumar

Active Director Director DIN 07048016
DIN 07048016 First appointment Jan 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2015
Shareholding value •••• Premium profile

About Sanjiv Kumar

Data last updated:

Sanjiv Kumar is a Director at Alleviate Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Alleviate Pharmaceuticals Private Limited reported revenue of ₹1.02 Cr (FY 2025).

DIN 07048016
Primary Designation Director
Industry Pharma
First Appointment 05 Jan 2015
Oldest Company Age 11 yrs
Largest company Alleviate Pharmaceuticals Private Limited · ₹1.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20152015₹1.02 Cr (FY 2025)Active

Board colleagues of Sanjiv Kumar

NameDINCompanyDesignation
Maheepal07301121Alleviate Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alleviate Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjiv Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjiv Kumar

Sanjiv Kumar currently holds 1 directorship: Alleviate Pharmaceuticals Private Limited (Director, since 05 Jan 2015, revenue ₹1.02 Cr (FY 2025)).

Sanjiv Kumar was first appointed on 05 Jan 2015 as Director at Alleviate Pharmaceuticals Private Limited.

The current boards of Sanjiv Kumar's companies include Maheepal (Alleviate Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available